Additionally, the presence of APOE4 was associated with a higher likelihood of AD-tau pathology (OR = 6.34, p < 0.001), while although not quite significant, AGD-tau prevalence was lower in the presence of APOE4 (OR = 0.49, p = 0.041). This evidence concerns the gene MAPT and Alzheimer disease.